Clinical Trials - KRRO

NCT IDTitleStatusPhasesStart DateCompletion DatePrimary Completion Date
NCT06677307A Phase 1/2a, Single- and Multiple-dose Escalation Study of KRRO-110RECRUITINGPHASE1, PHASE22025-01-132026-122026-12